Bosede Afolabi

In 2016, she obtained a Certificate in Biostatistics and Epidemiology from the Harvard T.Chan School of Public Health in Boston, U.S.[2] Bosede served as Senior House Officer (SHO) in Obstetrics and Gynaecology at Central Middlesex Hospital, London, and Hull Royal Infirmary, North Yorkshire, and SHO and Specialist Registrar in many UK Hospitals, before returning to Lagos, Nigeria in 1998.

[2] Bosede became a Senior Registrar for the Obstetrics and Gynecology Department at Lagos University Teaching Hospital in 2000 and later became a Consultant Obstetrician and Gynecologist in 2002, where she continues to serve until the present day.

She was featured on CNN African Voices for her work in sickle cell pregnancy and her teaching, research, and clinical outcome in obstetrics and efforts to reduce maternal mortality.

In September 2023, she discussed several research innovations including the approach by her team at CCTRIS for rapidly and effectively treating iron deficiency anaemia in pregnancy, at the 2023 Goalkeepers event hosted by the Bill & Melinda Gates Foundation during the 78th United Nations General Assembly, #goalkeepers2023.

[8][9] Bosede continues to reinforce her passion for childbearing, sickle cell and maternal mortality, which reflects in her many publications, interviews, and research articles on the topic.

Bosede is the principal investigator on a Bill and Melinda Gates Foundation grant for the IVON trial (Intravenous versus oral iron for iron deficiency anaemia in pregnant Nigerian women: a randomized controlled trial) as well as Country Principal Investigator on a grant for a study titled Preparedness and response to COVID-19: a global survey of maternal care providers - In-depth case study of large referral maternity wards in four countries in sub-Saharan Africa.

She is also the Country Principal Investigator for a randomized controlled trial on screening of Peripartum Cardiomyopathies using Artificial Intelligence (SPEC -AI) in Nigeria (2022-2023).